⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 1, 2024Clinical ophthalmologyOpen Access

A Randomized, Multicenter Phase 3 Clinical Trial Evaluating Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis

Kenneth R. Kenyon Eugene McLaurin Steven Silverstein John C Meyer Erik Anderson Ravi H Patel Paul J Gomes Erin Reilly Srilatha Vantipalli Matthew W Cheung Michael H. Goldstein

View Full Paper

Ask AI

Bookmark

Share

Abstract

To evaluate the efficacy and safety of a dexamethasone intracanalicular insert (DEX) for treatment of allergic conjunctivitis (AC).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kenyon et al. (2024) studied this question.

synapsesocial.com/papers/68e59fb2b6db64358753a66b https://doi.org/10.2147/opth.s476419

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Real-World Characteristics and Safety Outcomes of 10,000 Eyes Treated with Intracanalicular Dexamethasone Insert: An IRIS® Registry Analysis 2019-20212025
2Evaluating a Sustained-Release Dexamethasone Insert as Adjunctive Therapy for Inflammation and Pain Post-Corneal Transplantation2024 · 2 citations
3Postoperative Inflammation and Pain Management with Intracanalicular Dexamethasone Insert: Real-World ApplicationsEarly-Phase Clinical Trial · 2026
4Efficacy and Safety of Supraciliary Dexamethasone Implantation in Patients with Macular Edema: Preliminary and Comparative Study2024
5Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.RCT · 2011 · 30 citations